Skip to content

Clinical trials

Phase 1/2 Colorectal Neoplasms trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colorectal Neoplasms Phase: Phase 1/2 Country / region: United States Clear all

257 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20016
20023
20032
20044
20054
20063
20075
20083
20095
20109
20113
20128
20136
20145
20155
201612
201712
201816
201916
202016
202116
202214
202319
202420
202518
202612

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed98
Recruiting66
Terminated46
Active, not recruiting31
Unknown status8
Withdrawn5
Suspended2
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)10
Bristol-Myers Squibb8
M.D. Anderson Cancer Center7
Incyte Corporation6
Roswell Park Cancer Institute6
Revolution Medicines, Inc.5
Gilead Sciences4
Massachusetts General Hospital4
University of Southern California4
A2 Biotherapeutics Inc.3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colorectal Neoplasms257
Carcinoma, Non-Small-Cell Lung65
Colonic Neoplasms61
Pancreatic Neoplasms49
Neoplasm Metastasis42
Rectal Neoplasms42
Stomach Neoplasms41
Ovarian Neoplasms40
Breast Neoplasms30
Melanoma30

Trials

Showing 1 to 25 of 257. Each trial links to its page on Pharma Observatory.

157 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.